Propanc Biopharma, Inc. (PPCB) stock

PPCBNasdaqPharmaceutical PreparationsFiscal year ends June 30

Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 2/30

$1.94+0.02 (+1.09%)

Close on Nov 13, 2026Market cap $12.29MP/E –Yield –

Propanc Biopharma gross margin

Gross margin is gross profit as a percentage of revenue.

Propanc Biopharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?